Decrease of Pdzrn3 is required for heart maturation and protects against heart failure
Mathieu Pernot1, Béatrice Jaspard-Vinassa1, Alice Abelanet1
1Univ. Bordeaux, Inserm, UMR1034, Biology of Cardiovascular Diseases, 1 Avenue de Magellan, 33600, Pessac, France.
Insights
PDZRN3, an E3 ubiquitin ligase, regulates cardiomyocyte organization. Its dysregulation causes heart failure, but blocking PDZRN3 protects heart function, suggesting it as a therapeutic target.
Area of Science:
- Cardiology
- Molecular Biology
- Cell Biology
Background:
- Heart failure involves cardiomyocyte (CM) alterations at cell contact sites.
- Planar cell polarity (PCP) signaling is crucial for CM organization and cardiac function.
- PDZRN3, an E3 ubiquitin ligase, is implicated in PCP signaling and tissue patterning.
Purpose of the Study:
- To investigate the role of PDZRN3 in cardiomyocyte polarization and heart failure.
- To determine if PDZRN3 is a potential therapeutic target for heart failure.
Main Methods:
- Utilized mouse models with cardiomyocyte-specific PDZRN3 overexpression (OE) and knockout (KO).
- Analyzed cardiac function, CM morphology, and expression of key signaling molecules (PKC ζ, c-Jun, β-catenin).
- Examined the subcellular localization of intercalated disk proteins (Cx43, ZO1, Desmoglein 2).
Main Results:
- Moderate CM PDZRN3 OE induced eccentric hypertrophy and heart failure.
- CM-specific PDZRN3 KO completely protected against pressure-overload induced heart failure.
- PDZRN3 signaling altered junction protein localization, impairing CM polarization.
- PDZRN3 OE affected PKC ζ, c-Jun, and β-catenin levels, consistent with non-canonical Wnt signaling.
Conclusions:
- PDZRN3 controls a genetic program vital for heart maturation and function.
- Altered PDZRN3 levels disrupt CM organization and lead to heart failure.
- PDZRN3 is a novel therapeutic target for preventing and treating heart failure.
Abstract:
Heart failure is the final common stage of most cardiopathies. Cardiomyocytes (CM) connect with others via their extremities by intercalated disk protein complexes. This planar and directional organization of myocytes is crucial for mechanical coupling and anisotropic conduction of the electric signal in the heart. One of the hallmarks of heart failure is alterations in the contact sites between CM. Yet no factor on its own is known to coordinate CM polarized organization. We have previously shown that PDZRN3, an ubiquitine ligase E3 expressed in various tissues including the heart, mediates a branch of the Planar cell polarity (PCP) signaling involved in tissue patterning, instructing cell polarity and cell polar organization within a tissue. PDZRN3 is expressed in the embryonic mouse heart then its expression dropped significantly postnatally corresponding with heart maturation and CM polarized elongation. A moderate CM overexpression of Pdzrn3 (Pdzrn3 OE) during the first week of life, induced a severe eccentric hypertrophic phenotype with heart failure. In models of pressure-overload stress heart failure, CM-specific Pdzrn3 knockout showed complete protection against degradation of heart function. We reported that Pdzrn3 signaling induced PKC ζ expression, c-Jun nuclear translocation and a reduced nuclear ß catenin level, consistent markers of the planar non-canonical Wnt signaling in CM. We then show that subcellular localization (intercalated disk) of junction proteins as Cx43, ZO1 and Desmoglein 2 was altered in Pdzrn3 OE mice, which provides a molecular explanation for impaired CM polarization in these mice. Our results reveal a novel signaling pathway that controls a genetic program essential for heart maturation and maintenance of overall geometry, as well as the contractile function of CM, and implicates PDZRN3 as a potential therapeutic target for the prevention of human heart failure.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...


